20160128 EGA Regulatory and Scientific Affairs Conferenc

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

2 March 2017

Today, the European Parliament voted on the report on ‘Options […]

Read more

Joint Declaration for an ambitious EU industrial strategy

27 February 2017

Europe is the cradle of the manufacturing industry and has […]

Read more

EU-Canada Free Trade Agreement: an Opportunity to Create Manufacturing Jobs in the Generic and Biosimilar Medicines Industries

20 February 2017

Medicines for Europe welcomes the approval by the European Parliament […]

Read more

Joint statement on Shortages

2 February 2017

The European associations representing manufacturers of medicinal products, parallel distributors, […]

Read more

European Parliament prioritises Generic, Biosimilar and Value Added Medicines Competition to improve Access

31 January 2017

Today, the Environment, Public Health and Food Safety Committee (ENVI) voted […]

Read more

Building a 21st Century Regulatory Environment for Better Patient Access to Medicines

26 January 2017

This week in London, Medicines for Europe gathers national authorities, […]

Read more

Opportunities that Technology and Social Media Bring to Pharmacovigilance Explored in London this Week

25 January 2017

National authorities, regulators, industry leaders and pharmacists gathered in London […]

Read more

Subscribe to our newsletter